Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan.

Pharmaceuticals (Basel) · 2025 · PMC12472429 · PMID 41011236

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

By contrast, the reduction in sight-threatening retinopathy risk did not reach statistical significance (aHR 0.85, 95% CI 0.67–1.08) ( Table 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.